Personal care major Johnson & Johnson is working with biotech specialist Sequential Skin to investigate whether there are any new markers for skin health, particularly those linked to acne and ageing.
Consumer interest in skin-friendly beauty products continues its rise, prompting an acceleration in microbiome claims validation and product testing both in vitro and in vivo, say testing experts.
UK-Singapore headquartered biotech startup Sequential Skin has taken a solid stride into B2B microbiome testing with the debut of its end-to-end in vivo service for consumer care companies.
UK-Singapore headquartered biotech startup Sequential Skin has secured more funding in its latest seed round that it plans to use for global expansion of its at-home skin diagnostics patch, in both a B2B and D2C capacity, its CEO says.
Skin microbiome science and innovation is fast-evolving, with a plethora of tools, ingredients and research efforts spotlighting key areas of opportunity. But where exactly is the sector headed? And what might next-generation NPD look like?